A metabolite of methotrexate
Related Products
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

7-hydroxy Methotrexate (sodium salt)

Item No. 21788

Technical Information
Formal Name
N-[4-[[(2,4-diamino-7,8-dihydro-7-oxo-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid, trisodium salt
Synonyms
  • 7-hydroxy MTX
Molecular Formula
C20H19N8O6 • 3Na
Formula Weight
Purity
≥95%
A solid
DMF: 14 mg/mlDMSO: 3 mg/mlPBS (pH 7.2): 1 mg/ml
SMILES
[O-]C(C(CN(C1=CC=C(C(N[C@@H](CCC([O-])=O)C([O-])=O)=O)C=C1)C)=N2)=NC3=C2C(N)=NC(N)=N3.[Na+].[Na+].[Na+]
InChi Code
InChI=1S/C20H22N8O6.3Na/c1-28(8-12-18(32)26-16-14(23-12)15(21)25-20(22)27-16)10-4-2-9(3-5-10)17(31)24-11(19(33)34)6-7-13(29)30;;;/h2-5,11H,6-8H2,1H3,(H,24,31)(H,29,30)(H,33,34)(H5,21,22,25,26,27,32);;;/q;3*+1/p-3/t11-;;;/m0.../s1
InChi Key
UGUJBPCBGFUHQR-XVSRHIFFSA-K
Shipping & Storage Information
Storage
4°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    7-hydroxy Methotrexate (7-hydroxy MTX) is a phase I metabolite of MTX (Item No. 13960), which is converted by hepatic aldehyde oxidases.1 Elimination of 7-hydroxy MTX is associated with the multi-drug transporters Abcc2, Abcc3, and Abcg2 in transgenic mouse models. It and the parent compound rapidly accumulate when all three transporters are absent.2 Formulations containing methotrexate have been used in the treatment of cancer, autoimmune diseases, ectopic pregnancy, and for the induction of medical abortions.3,4 Various methods have been described to quantify 7-hydroxy MTX levels during cancer therapy to avoid toxicity.5,6

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Johns, D.G., Iannotti, A.T., Sartorelli, A.C., et alThe relative toxicites of methotrexate and aminopterin. Biochem. Pharmacol. 15(5), 555-561 (1966).

    2. Vlaming, M.L.H., van Esch, A., Pala, Z., et alAbcc2 (Mrp2), Abcc3 (Mrp3), and Abcg2 (Bcrp1) are the main determinants for rapid elimination of methotrexate and its toxic metabolite 7-hydroxymethotrexate in vivo. Mol. Cancer. Ther. 8(12), 3350-3359 (2009).

    3. Cutolo, M., Sulli, A., Pizzorni, C., et alAnti-inflammatory mechanisms of methotrexate in rheumatoid arthritis. Ann. Rheum. Dis. 60(8), 729-735 (2001).

    4. Christin-Maitre, S., Bouchard, P., and Spitz, I.M. Medical termination of pregnancy. N. Engl. J. Med. 342(13), 946-956 (2000).

    5. Schofield, R.C., Ramanathan, L.V., Murata, K., et alDevelopment of an assay for methotrexate and its metabolites 7-hydroxy methotrexate and DAMPA in serum by LC-MS/MS. Methods in Molecular Biology 213-222 (2016).

    6. Klapkova, E., Kukacka, J., Kotaska, K., et alThe influence of 7-OH methotrexate metabolite on clinical relevance of methotrexate determination. Clin. Lab. 57(7-8), 599-606 (2011).